convalescent COVID-19 plasma

Convalescent COVID-19 plasma is a biological therapy derived from the blood of individuals who have recovered from a SARS-CoV-2 infection. This plasma contains high titers of neutralizing antibodies that specifically target the virus. When administered to patients with active COVID-19, it provides passive immunity, helping to neutralize the viral load and potentially mitigating the inflammatory response associated with severe disease. The Christ Hospital initiated a clinical program to evaluate this treatment in high-risk hospitalized patients, particularly those showing signs of cardiac injury (elevated troponin) or requiring mechanical ventilation, with the goal of reducing mortality and the duration of intensive care support.

Other names

Convalescent COVID 19 PlasmaCOVID-19 convalescent plasmaCOVID19 convalescent plasmaCOVID 19 convalescent plasmaCP